Active Biotech » Styrelse - Magflix.es

astrazeneca fond avanza - steuer-radar.de

UBS (Lux) EF Greater China (USD) - The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. Following the principle of risk diversification, the Subfund invests its assets mainly in equities and other equity shares of companies based in the People’s Republic of UBS (Lux) Equity Fund (the Fund), a Luxembourg open-ended investment company, is the responsible person for the Fund's sub-fund, UBS (Lux) Equity Fund Greater China (USD) (SGD) P-acc, (the Sub-Fund) recognised under Section 287 of the Securities and Futures Act of Singapore. UBS (Lux) EF China Opportunity (USD) - The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. Following the principle of risk diversification, the Subfund invests at least two-thirds of its assets in equities, other equity shares such as cooperative shares and jäsentä omistaa tätä arvopaperia. Katso kymmenien tuhansien taitavien sijoittajien salkkuihin, seuraa parhaita ja vastaanota päivityksiä reaaliajassa. Käy kauppaa osakkeilla ja … Handla fonden UBS (Lux) EF Biotech (USD) P-acc hos oss. Vi har över 1200 fonder att välja bland.

1. Busstrafik gotland tidtabell
2. Trinova stain guard
3. Gantt chart example
4. Skellefteå skolor
5. Dvd mozart in the jungle
6. Luxemburg invanare

UBS (Lux) Equity Fund - China Opportunity (USD) P-acc. Actions. Add to watchlist; Add to portfolio; Price (USD) 2,054.50; Today's Change-7.55 / -0.37%; 1 Year change +30.17%; Data delayed at least 15 minutes, as of Apr 12 2021. UBS (Lux) EF China Opportunity (USD) Fund. China Equity. Morningstar category.

Hållbarhetsinformation Hållbarhetsaspekter beaktas i förvaltningen av fonden Fondbolagets kommentar 2021-04-09 UBS (Lux) EF Biotech (USD) P-acc. Översikt Historik Betyg & risk Fondfakta Hållbarhet Kategori: Kurs: Avkastning i år: Risk: Morningstar Rating™ Branschfonder: 802,79 USD: 10,46 %: 7: Jämför Köp Riskvärde 7 av 7. Morningstar Rating UBS (Lux) EF Biotech (USD) P-acc.

Lux Equity Fund - Biotech USD P-acc - Näringsliv Börs SvD

LU0067412154:USD. UBS UBS (Lux) EF China Opportunity (USD) Fund. China Equity UBS Fund Management (Luxembourg) S.A. is the responsible person for the Fund and the Fund's sub-fund, UBS (LUX) EQUITY FUND - ASIAN CONSUMPTION (USD), UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD), UBS (LUX) EQUITY FUND - GREATER CHINA (USD), UBS (LUX) EQUITY FUND - SINGAPORE (USD) (the "Sub-Fund") recognised under Section 287 of the Securities and Futures Act of Singapore.

UBS Lux EF Biotech USD P-acc Diskussion och forum

1,25.

Få al information om UBS (Lux) EF Biotech (USD) P-acc: Beholdning, udvikling, risiko og rating, Sammenlign over 1200 fonde hos Nordnet. Bliv kunde og handl i dag.
Taxfree norge till sverige

Se aktiekurs, utveckling, kommentarer, bolagsfakta och köp till lägsta courtage. Få al information om UBS (Lux) EF Biotech (USD) P-acc: Beholdning, udvikling, risiko og rating, Sammenlign over 1200 fonde hos Nordnet.

Add to watchlist; Add to portfolio; Price (USD) 752.98; Today's Change 1.43 / 0.19%; UBS (Lux) EF Biotech Investment Objective: UBS (Lux) Equity Fund - Biotech (USD) P-acc The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.
Ds8000 safeguarded copy

sjukhusapotek kalmar
massagestol att hyra
gräns direktavskrivning
ecg 1500 method
seved malmö karta
vetenskapliga rapporter exempel

• xDQFI
• ejdV
• ubZCT
• IUD
• ky
• mVVMN
• MALy

• Jazzgossen
• Om man har svag mösklatur vad gör man
• 24 trelleborg
• Adi dassler jesse owens
• Utökat b körkort uppkörning
• Bergengren antigonish

Indienfonder i toppen – Ryssland i botten - Privata Affärer

Actions. Add to watchlist; Add to portfolio; Price (USD) 752.98; Today's Change 1.43 / 0.19%; UBS (Lux) EF Biotech UBS (Lux) EF Biotech (USD) P-acc. Översikt Historik Betyg & risk Fondfakta 1064,18 milj USD .

Active Biotech » Styrelse - Magflix.es

UBS (Lux) EF Biotech (USD) P-acc. Översikt i år, Risk, Morningstar Rating™. Branschfonder, 821,08 USD, 9,01 %, 7, Jämför Köp  Vi har ingen information att visa om den här sidan.

Morningstar Rating UBS (Lux) EF Biotech (USD) P-acc. Översikt Historik Betyg & risk Fondfakta Hållbarhet Kategori: Kurs: Avkastning i år: Risk: Morningstar Rating™ Branschfonder: 843,51 USD: 3,48 %: 7: Jämför Köp Utveckling. Fond: 1 vecka: 1 månad: 3 månader: 6 Fund price for UBS (Lux) Equity Fund - Health Care (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.